A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mesa Laboratories Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 10,715 shares of MLAB stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,715
Previous 24,695 56.61%
Holding current value
$1.41 Million
Previous $2.14 Million 35.06%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$87.73 - $140.86 $1.23 Million - $1.97 Million
-13,980 Reduced 56.61%
10,715 $1.39 Million
Q2 2024

Aug 14, 2024

SELL
$84.94 - $122.22 $771,679 - $1.11 Million
-9,085 Reduced 26.89%
24,695 $2.14 Million
Q1 2024

May 15, 2024

BUY
$90.62 - $114.1 $590,117 - $743,019
6,512 Added 23.88%
33,780 $3.71 Million
Q4 2023

Feb 14, 2024

BUY
$84.55 - $115.06 $95,541 - $130,017
1,130 Added 4.32%
27,268 $2.86 Million
Q3 2023

Nov 14, 2023

SELL
$104.28 - $143.36 $2.17 Million - $2.99 Million
-20,851 Reduced 44.37%
26,138 $2.75 Million
Q2 2023

Aug 14, 2023

BUY
$125.33 - $184.35 $5.33 Million - $7.85 Million
42,562 Added 961.42%
46,989 $6.04 Million
Q1 2023

May 15, 2023

SELL
$163.15 - $203.76 $7.52 Million - $9.4 Million
-46,111 Reduced 91.24%
4,427 $773,000
Q4 2022

Feb 14, 2023

BUY
$118.55 - $188.84 $3.35 Million - $5.34 Million
28,257 Added 126.82%
50,538 $8.4 Million
Q3 2022

Nov 14, 2022

BUY
$139.58 - $214.98 $2.47 Million - $3.8 Million
17,680 Added 384.26%
22,281 $3.14 Million
Q2 2022

Aug 15, 2022

SELL
$182.13 - $260.0 $1.86 Million - $2.66 Million
-10,229 Reduced 68.98%
4,601 $938,000
Q1 2022

May 16, 2022

BUY
$248.18 - $329.02 $3.3 Million - $4.37 Million
13,291 Added 863.61%
14,830 $3.78 Million
Q4 2021

Feb 14, 2022

SELL
$295.95 - $332.41 $263,691 - $296,177
-891 Reduced 36.67%
1,539 $504,000
Q3 2021

Nov 15, 2021

SELL
$266.92 - $322.44 $852,008 - $1.03 Million
-3,192 Reduced 56.78%
2,430 $735,000
Q2 2021

Aug 16, 2021

SELL
$235.0 - $272.85 $1.29 Million - $1.5 Million
-5,508 Reduced 49.49%
5,622 $1.52 Million
Q1 2021

May 17, 2021

SELL
$243.02 - $297.01 $233,542 - $285,426
-961 Reduced 7.95%
11,130 $2.71 Million
Q4 2020

Feb 16, 2021

BUY
$258.4 - $289.99 $1.78 Million - $1.99 Million
6,877 Added 131.89%
12,091 $3.47 Million
Q3 2020

Nov 16, 2020

SELL
$211.1 - $255.87 $1.66 Million - $2.02 Million
-7,882 Reduced 60.19%
5,214 $1.33 Million
Q2 2020

Aug 14, 2020

BUY
$208.55 - $264.25 $2.12 Million - $2.69 Million
10,174 Added 348.19%
13,096 $2.84 Million
Q1 2020

May 15, 2020

SELL
$190.69 - $270.25 $654,829 - $928,038
-3,434 Reduced 54.03%
2,922 $660,000
Q4 2019

Feb 14, 2020

BUY
$213.21 - $251.5 $1.36 Million - $1.6 Million
6,356 New
6,356 $1.59 Million
Q2 2019

Aug 14, 2019

SELL
$185.45 - $260.0 $737,163 - $1.03 Million
-3,975 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$204.75 - $240.24 $248,976 - $292,131
1,216 Added 44.07%
3,975 $0
Q4 2018

Feb 14, 2019

SELL
$171.0 - $221.34 $94,221 - $121,958
-551 Reduced 16.65%
2,759 $574,000
Q3 2018

Nov 13, 2018

BUY
$181.0 - $222.93 $599,110 - $737,898
3,310 New
3,310 $0

Others Institutions Holding MLAB

About MESA LABORATORIES INC


  • Ticker MLAB
  • Exchange NASDAQ
  • Sector Technology
  • Industry Scientific & Technical Instruments
  • Shares Outstandng 5,317,270
  • Market Cap $698M
  • Description
  • Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the ...
More about MLAB
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.